Metabolism of 1α,25(OH)2D3 and its 20-epi analog integrates clonal expansion, maturation and apoptosis during HL-60 cell differentiation

This publication has 55 references indexed in Scilit:

• Expression of Retinoic Acid Receptor- Sensitizes Prostate Cancer Cells to Growth Inhibition Mediated by Combinations of Retinoids and a 19-nor Hexafluoride Vitamin D3 Analog
  Endocrinology, 1998
• The Vitamin D Analog, KH1060, Is Rapidly Degraded Both in Vivo and in Vitro via Several Pathways: Principal Metabolites Generated Retain Significant Biological Activity
  Endocrinology, 1997
• The Retinoblastoma Protein Pathway in Cell Cycle Control and Cancer
  Experimental Cell Research, 1997
• Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity
  Journal of Cellular Biochemistry, 1997
• Vitamin D3 analogs and their 24-Oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects
  Journal of Cellular Biochemistry, 1997
• Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin
  Journal of Molecular Endocrinology, 1997
• 1α,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1α,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells
  The Journal of Steroid Biochemistry and Molecular Biology, 1996
• 20-EPI-vitamin D3 analogues: A novel class of potent regulators of cell growth and immune responses
  Biochemical Pharmacology, 1991
• Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.
  Proceedings of the National Academy of Sciences, 1981
• 1,25-DIHYDROXYVITAMIN D₃AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTURE
  Endocrinology, 1981